{"url":"https://lda.senate.gov/api/v1/filings/e756b2fb-5df7-400a-8596-6c0641ff4b68/","filing_uuid":"e756b2fb-5df7-400a-8596-6c0641ff4b68","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2018,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/e756b2fb-5df7-400a-8596-6c0641ff4b68/print/","filing_document_content_type":"text/html","income":"15000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Romano Romani","dt_posted":"2019-01-18T16:36:08.933000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"517 C Street, NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":30792,"url":"https://lda.senate.gov/api/v1/registrants/30792/","house_registrant_id":30115,"name":"PARRY, ROMANI, DECONCINI & SYMMS","description":"Consulting","address_1":"517 C Street NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROMANO ROMANI","contact_telephone":"+1 202-547-4000","dt_updated":"2026-04-23T11:31:32.295882-04:00"},"client":{"id":136222,"url":"https://lda.senate.gov/api/v1/clients/136222/","client_id":1004797,"name":"BELMAR PHARMACY","general_description":"Compounding Pharmacy","client_government_entity":false,"client_self_select":null,"state":"CO","state_display":"Colorado","country":"US","country_display":"United States of America","ppb_state":"CO","ppb_state_display":"Colorado","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-07-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Monitoring FDA Implementation of legislation affecting Compounding Pharmacies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13252,"prefix":null,"prefix_display":null,"first_name":"ROMANO","nickname":null,"middle_name":null,"last_name":"ROMANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5895,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"SYMMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":31170,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}